PEDRAM TAHER: Open Payments
NPI 1669625125 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 31 payments from 17 companies in 2025. Trend: 2023 $608 · 2024 $834 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $138 |
| Aimmune Therapeutics, Inc. | 3 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $65 |
| UCB, Inc. | 2 | $58 |
| PFIZER INC. | 2 | $50 |
| Eisai Inc. | 2 | $48 |
| Globus Medical, Inc. | 1 | $43 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Dexcom, Inc. | 1 | $30 |
Products named: REXULTI, ZENPEP, Kerendia, XIFAXAN, Fintepla, PAXLOVID, Leqembi, Senza.
Industry payments across CA — which companies pay providers there.
